GlassScriptPhysician profile
Kiin Kim
NPI 1558711051
$2,298.57
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $20.38 · 2021: $651 · 2022: $606 · 2023: $655 · 2024: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $868 · Travel and Lodging: $9.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.42 |
| Travel and Lodging | $9.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $602.53 | 2021-2023 | Intellis Adaptivestim |
| Hollister Incorporated | $236.37 | 2021-2023 | Vapro Plus Pocket |
| International Rehabilitative Sciences, INC | $208.99 | 2021-2024 | Rs 4i Plus Sequential Stimulator |
| Janssen Biotech, INC. | $198.31 | 2023-2024 | Tremfya |
| Electronic Waveform Lab, INC. | $170.52 | 2021-2022 | |
| Ucb, INC. | $149.56 | 2022-2024 | Cimzia |
| Merz North America, INC. | $144.74 | 2019-2020 | |
| Lilly USA, LLC | $129.64 | 2023 | Taltz |
| Radius Health, INC. | $118.21 | 2021 | |
| Neurometrix INC | $106.14 | 2023 | |
| Amgen INC. | $54.67 | 2021-2024 | Krystexxa |
| Mallinckrodt Hospital Products INC. | $31.63 | 2024 | Acthar |
| Tersera Therapeutics LLC | $30.24 | 2022 | |
| Fresenius Kabi USA, LLC | $30.15 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.68 | 2023 | Ofev |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $19.19 | 2019 | |
| Redhill Biopharma INC. | $17.91 | 2021 | |
| Ibsa Pharma INC. | $14.32 | 2023 | Tirosint, Licart |
| Forte Bio-Pharma LLC | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiin Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.